308 related articles for article (PubMed ID: 35081129)
1. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
2. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
Sendelius M; Axelsson J; Liu P; Roos S
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri.
Luo H; Li P; Wang H; Roos S; Ji B; Nielsen J
BMC Biotechnol; 2021 Jul; 21(1):46. PubMed ID: 34330235
[TBL] [Abstract][Full Text] [Related]
4. Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Jalasvuori H; Haukioja A; Tenovuo J
Arch Oral Biol; 2012 Dec; 57(12):1633-8. PubMed ID: 23010217
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection.
Zhang D; Li R; Li J
Res Vet Sci; 2012 Aug; 93(1):366-73. PubMed ID: 21764090
[TBL] [Abstract][Full Text] [Related]
6. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Van Holm W; Verspecht T; Carvalho R; Bernaerts K; Boon N; Zayed N; Teughels W
Mol Oral Microbiol; 2022 Dec; 37(6):266-275. PubMed ID: 36075698
[TBL] [Abstract][Full Text] [Related]
7. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features.
Saulnier DM; Santos F; Roos S; Mistretta TA; Spinler JK; Molenaar D; Teusink B; Versalovic J
PLoS One; 2011 Apr; 6(4):e18783. PubMed ID: 21559529
[TBL] [Abstract][Full Text] [Related]
8. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938.
Rosander A; Connolly E; Roos S
Appl Environ Microbiol; 2008 Oct; 74(19):6032-40. PubMed ID: 18689509
[TBL] [Abstract][Full Text] [Related]
9. Development of a strain-specific real-time PCR assay for enumeration of a probiotic Lactobacillus reuteri in chicken feed and intestine.
Sattler VA; Mohnl M; Klose V
PLoS One; 2014; 9(2):e90208. PubMed ID: 24587284
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Gupta N; Ferreira J; Hong CHL; Tan KS
Sci Rep; 2020 Oct; 10(1):16189. PubMed ID: 33004948
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
[TBL] [Abstract][Full Text] [Related]
12.
Maya-Barrios A; Lira-Hernandez K; Jiménez-Escobar I; Hernández L; Ortiz-Hernandez A; Jiménez-Gutiérrez C; López-Velázquez G; Gutiérrez-Castrellón P
Benef Microbes; 2021 Apr; 12(2):137-145. PubMed ID: 33789556
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
Wang Z; Wang L; Chen Z; Ma X; Yang X; Zhang J; Jiang Z
J Microbiol Biotechnol; 2016 Jun; 26(6):1018-25. PubMed ID: 26907754
[TBL] [Abstract][Full Text] [Related]
14. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
15. Real-Time PCR Assays for the Specific Identification of Probiotic Strains Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC (NCIMB 30242).
Shehata HR; Ragupathy S; Allen S; Leyer G; Newmaster SG
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):837-846. PubMed ID: 32780278
[TBL] [Abstract][Full Text] [Related]
16. Culturing the Chicken Intestinal Microbiota and Potential Application as Probiotics Development.
Ma K; Chen W; Lin XQ; Liu ZZ; Wang T; Zhang JB; Zhang JG; Zhou CK; Gao Y; Du CT; Yang YJ
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769368
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
Fåk F; Bäckhed F
PLoS One; 2012; 7(10):e46837. PubMed ID: 23056479
[TBL] [Abstract][Full Text] [Related]
18. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications.
Sulemankhil I; Parent M; Jones ML; Feng Z; Labbé A; Prakash S
Can J Microbiol; 2012 Jun; 58(6):776-87. PubMed ID: 22642667
[TBL] [Abstract][Full Text] [Related]
20. Experimental Evaluation of Host Adaptation of Lactobacillus reuteri to Different Vertebrate Species.
Duar RM; Frese SA; Lin XB; Fernando SC; Burkey TE; Tasseva G; Peterson DA; Blom J; Wenzel CQ; Szymanski CM; Walter J
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28389535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
